Industry Updates for the Psychedelics World

Psychedelics News

Industry

11 Oct 2022

American Psychedelic Practitioners Association (APPA) Launches Non-Profit

The American Psychedelic Practitioners Association (APPA) has announced the launch of their organization, establishing safe, ethical and accessible psychedelic therapy and specific focus Psychedelic Assisted Therapy (PAT)....

By Microdose

Industry

7 Oct 2022

atai Life Sciences Doses First Patient in New DMT Clinical Trial

On Wednesday, atai published a press release celebrating the first patient being dosed in their Phase 1 DMT safety trial....

By James Hallifax

Industry

5 Oct 2022

PharmaTher Granted U.S. Patent Covering Ketamine for Parkinson’s

PharmaTher Holdings Announces Grant of U....

By Microdose NewsDesk

Industry, Science

4 Oct 2022

Is Ketamine Telehealth Here to Stay?

Ketamine telehealth has been booming....

By Patrick McConnell

Join Our Newsletter for Exclusive Updates, Stories, and More

Industry

28 Sep 2022

Atai Life Sciences Launches Phase 1 MDMA Trial

atai Life Sciences Announces Initiation of Phase 1 Trial for its MDMA Derivative, EMP-01...

By Jason Najum

Industry

27 Sep 2022

Cybin Buys License to Mindset Pharma’s Psychedelic Compounds

Cybin Obtains Exclusive License to a Novel Catalog of Psychedelic-Based Compounds...

By Microdose NewsDesk

Industry

23 Sep 2022

GH Research Presents Trial Findings at ICPR Conference

As a public service, we're sharing the presentation the company released this week....

By Microdose NewsDesk

Industry, Science

22 Sep 2022

APA Issues Position Statement on Psychedelics

This past July, America’s oldest medical association, the American Psychiatric Association (APA), released an official position statement related to psychedelics entitled “Position Statement on the Use of Psychedelic and Empathogenic...

By Phillips Lytle

Industry

21 Sep 2022

HAVN Life Shutting Down?

Unfortunate news for investors in HAVN Life Sciences as it seems the company may be closing down its operations....

By Microdose NewsDesk

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result